Woodline Partners’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-474,613
Closed -$3.67M 1116
2025
Q3
$3.67M Sell
474,613
-1,085,829
-70% -$8.47M 0.02% 624
2025
Q2
$13.6M Buy
+1,560,442
New +$11.3M 0.07% 366
2024
Q1
Sell
-241,511
Closed -$5.2M 632
2023
Q4
$5.2M Buy
+241,511
New +$4.46M 0.06% 316
2023
Q3
Sell
-196,235
Closed -$4.97M 731
2023
Q2
$4.97M Buy
+196,235
New +$4.94M 0.06% 291
2021
Q3
Sell
-6,092
Closed -$1.01M 739
2021
Q2
$1.01M Buy
+6,092
New +$987K 0.02% 426
2020
Q2
Sell
-27,343
Closed -$4.24M 190
2020
Q1
$4.24M Buy
+27,343
New +$3.18M 0.3% 97

Other funds holding TDOC

Woodline Partners's TDOC Position: Q4 2025 in Review

Woodline Partners sold out of Teladoc Health (TDOC) in Q4 2025, closing a stake of 474,613 shares — an estimated $3.67M sold.

Woodline Partners first reported a position in TDOC in Q1 2020 and held it in 6 quarters. The position peaked at $13.6M in Q2 2025. 344 funds tracked by Wall St. Rank hold TDOC as of Q4 2025.

  • Woodline Partners reported no remaining Teladoc Health position as of Q4 2025 after selling out during the quarter.
  • Woodline Partners sold 474,613 Teladoc Health shares in Q4 2025, an estimated $3.67M.
  • Woodline Partners first reported a position in Teladoc Health in Q1 2020 and held it in 6 quarters.
  • Woodline Partners's Teladoc Health position peaked at $13.6M in Q2 2025.
  • 344 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2025.

Based on Woodline Partners's 13F filing for Q4 2025, filed 17 Feb 2026.